Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 378. Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, Rueckert C, Pezzini A, Poli L, Padovani A, et al. Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibril- lation: effect of anticoagulation and its timing: the RAF Study. Stroke. 379. Markus HS, Hayter E, Levi C, Feldman A, Venables G, Norris J; CADISS Trial Investigators. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14:361 367. doi: 10.1016/ 380. Larsson SC, King A, Madigan J, Levi C, Norris JW, Markus HS. Prognosis of carotid dissecting aneurysms: results from CADISS and a systematic review. Neurology. 2017;88:646 652. doi: 381. Ahlhelm F, Benz RM, Ulmer S, Lyrer P, Stippich C, Engelter S. Endovascular treatment of cervical artery dissection: ten case reports and review of the literature. Interv Neurol. 2013;1:143 150. doi: 382. Kim JT, Heo SH, Park MS, Chang J, Choi KH, Cho KH. Use of anti- thrombotics after hemorrhagic transformation in acute ischemic stroke. PLoS One. 2014;9:e89798. doi: 10.1371/journal.pone.0089798 383. England TJ, Bath PM, Sare GM, Geeganage C, Moulin T, O Neill D, Woimant F, Christensen H, De Deyn P, Leys D, et al; TAIST Investigators. Asymptomatic hemorrhagic transformation of infarction and its relation- ship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial. Stroke. 2010;41:2834 2839. 384. Nissen SE, Stroes E, Dent-Acosta RE, Rosenson RS, Lehman SJ, Sattar N, Preiss D, Bruckert E, Ce ka R, Lepor N, et al; GAUSS-3 Investigators. Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial. JAMA. 2016;315:1580 1590. doi: 10.1001/jama.2016.3608 385. 